Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Slenyto for sleep disturbances in children with ASD
NCT04233502Phase 3Withdrawn
- Sponsor
- Neurim Pharmaceuticals
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of melatonin in Insomnia, sponsored by Neurim Pharmaceuticals. Planned start Sep 2020; status: withdrawn.
02
Drugs
melatonin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04233502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233502.